Latest News and Press Releases

EXTON, Pa., Dec. 12, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the completion of its previously announced underwritten public offering of 10,350,000 shares of newly...

EXTON, Pa., Dec. 9, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the underwriters of its recent public offering of 9,000,000 shares of common stock have exercised in...

EXTON, Pa., Dec. 8, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that The New England Journal of Medicine (NEJM) and the Center for Disease Control and Prevention's (CDC)...

EXTON, Pa., Dec. 7, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the pricing of an underwritten public offering of 9,000,000 shares of newly issued common stock at $16.75...

EXTON, Pa., Nov. 28, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it plans to offer 7,000,000 shares of its common stock in a public offering. ViroPharma also...

EXTON, Pa., Nov. 28, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has completed enrollment in its Phase 2 clinical study for maribavir, an oral antiviral drug...

EXTON, Pa., Nov. 22, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Lazard Capital Markets Life Sciences Conference, at 1:30 P.M. EST on...

EXTON, Pa., Nov. 14, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has been selected to become a member of the NASDAQ Biotechnology Index(R). ViroPharma's...

EXTON, Pa., Nov. 11, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the 2005 Credit Suisse First Boston Health Care Conference, at 3:30 p.m. MST...

EXTON, Pa., Nov. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the company will host a conference call and live audio webcast today at 4:30 p.m. to discuss the...